Broncus Technologies Lands $38M
Mountain View-based Broncus Technologies, which is developing medical devices for treating emphysema, said Thursday that it has raised $38M in a Series G Funding. The round was led by Ares Life Sciences AG, which invested $25M in the firm. Other investors in the firm included Abingworth, Bio*One/Singapore, Charter Ventures, HBM BioVentures, JAIC America, Menlo Ventures, Pac-Link Ventures, Saints Capital and Sightline Ventures. According to Broncus, Dr. Beat Merz of Ares Life Sciences joins the board along with the funding.
posted on Thursday, December 4, 2008 (Link to more information)
Related companies:
Broncus Technologies
Related stories:
> Broncus Raises $29.5M
> PneumRx Buys Assets From Broncus Technologies
> Broncus Technologies Files For IPO
> Broncus Technologies Pulls IPO
> Jacent Technologies Lands $6.7M
silicontap.com Home